Evidence map›Paper›PMID 24979721›Full record

ArticleOncotarget2014

Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.

Christina A Von Roemeling, Laura A Marlow, Derek C Radisky, Austin Rohl, Hege Ekeberg Larsen, Johnny Wei, Heather Sasinowska, Heng Zhu, Richard Drake, Maciek Sasinowski and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. GeneChip expression profiling identifiedAnnals of translational medicine · 2022
    Article
  8. Fucosylation in Urological Cancers.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. LowerCancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Christina A Von RoemelingDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Laura A MarlowDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Derek C RadiskyDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Austin RohlDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Hege Ekeberg LarsenDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Johnny WeiDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Heather SasinowskaIncogen, Inc., Jacksonville, Florida.
Heng ZhuDepartment of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Jacksonville, Florida.
Richard DrakeMUSC Proteomics Center, Jacksonville, Florida.
Maciek SasinowskiIncogen, Inc., Jacksonville, Florida.
Han W TunDivision of Hematology and Oncology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
John A CoplandDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida.
Mayo Clinic in Florida · USIncogen (United States) · USSylvester Comprehensive Cancer Center · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
Proteome Characterization Center: A Genoproteomics Pipeline for Cance ResearchU24CA160036 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2011 to 2016
$10.7M
Visual Programming Tool for Integrated Gene/Protein Networks in Cancer ResearchR44CA125807 · NCI · INCOGEN, INC. · PI SASINOWSKI, MACIEK · 2008 to 2011
$3.4M
RhoB in cancer pathogenesis and as a target in combinatorial therapyR01CA136665 · NCI · MAYO CLINIC JACKSONVILLE · PI COPLAND, JOHN A., SMALLRIDGE, ROBERT · 2010 to 2014
$1.6M
TGF Beta receptor biology in human renal cell carcinomaR01CA104505 · NCI · MAYO CLINIC JACKSONVILLE · PI COPLAND, JOHN A. · 2004 to 2009
$1.4M
NCI NIH HHS 5R44CA125807NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA104505NCI NIH HHS R01CA104505NCI NIH HHS R01CA104505-05S1NCI NIH HHS R01 CA136665NCI NIH HHS R01CA136665NCI NIH HHS R44 CA125807NCI NIH HHS U24 CA160036
6 · The paper itself

Abstract

Currently there is a lack of targeted therapies that lead to long-term attenuation or regression of disease in patients with advanced clear cell renal cell carcinoma (ccRCC). Our group has implemented a high-throughput genetic analysis coupled with a high-throughput proliferative screen in order to investigate the genetic contributions of a large cohort of overexpressed genes at the functional level in an effort to better understand factors involved in tumor initiation and progression. Patient gene array analysis identified transcripts that are consistently elevated in patient ccRCC as compared to matched normal renal tissues. This was followed by a high-throughput lentivirus screen, independently targeting 195 overexpressed transcripts identified in the gene array in four ccRCC cell lines. This revealed 31 'hits' that contribute to ccRCC cell proliferation. Many of the hits identified are not only presented in the context of ccRCC for the first time, but several have not been previously linked to cancer. We further characterize the function of a group of hits in tumor cell invasion. Taken together these findings reveal pathways that may be critical in ccRCC tumorigenicity, and identifies novel candidate factors that could serve as targets for therapeutic intervention or diagnostic/prognostic biomarkers for patients with advanced ccRCC.

Indexed as

Carcinoma, Renal CellCell Line, TumorCell MovementCell ProliferationDown-RegulationGene Expression ProfilingGenomicsHigh-Throughput Nucleotide SequencingHumansKidney Neoplasms

Identifiers

PMID24979721
PMCPMC4170622
OpenAlexW1552667295

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.